Market Cap: $3.13B
AI
AtriCure, Inc.
ATRC
NASDAQ (NASDAQ Global Market)USD
Market Cap: $3.13B
AtriCure (Ticker: ATRC) has recently achieved a significant milestone with the completion of patient enrollment in its pivotal clinical trial, BoxX-NoAF, one year ahead of schedule. This accelerated t…
Analyst Focus Narrows on AtriCure Divergent analyst assessments point to execution and clinical uncertainty Six analysts are conducting focused reviews of AtriCure this quarter, producing a range of v…
Atricure posts fourth-quarter report after market close Atricure Inc. (NASDAQ: ATRC) files its fourth-quarter report on Tuesday, Feb. 17, 2026 at 4:01 p.m., prompting close scrutiny of operational and…
Latest filing flags expected operational details AtriCure Inc. (NASDAQ: ATRC) files its fourth-quarter report at 04:01 PM ET on Feb. 17, 2026, a timing that signals to customers, partners and regulato…
AtriCure files fourth-quarter results, directing attention to procedural growth and commercial execution AtriCure issues its fourth-quarter report on Tuesday, February 17, 2026 at 04:01 PM, a filing t…
AtriCure Focuses on Growth Amidst Strong Market Demand AtriCure, a leader in medical devices for cardiac and thoracic surgery, continues to thrive in a competitive landscape characterized by increasin…
AtriCure's Focus on Growth: Innovations in Cardiac Surgery AtriCure, a leader in the medical device industry specializing in cardiac surgery solutions, continues to drive innovation in its product off…
AtriCure’s Surge in Demand Highlights Growth in Cardiac Ablation Market AtriCure, a leader in medical devices for cardiac ablation, is experiencing a significant uptick in demand for its innovative pr…
I apologize, but it seems that there is no specific content provided for me to summarize. Please share the details or text you would like summarized, and I will gladly assist you in creating the artic…
AtriCure's Role in Advancing Atrial Fibrillation Treatment AtriCure, Inc., a prominent entity in the realm of surgical solutions for atrial fibrillation (Afib), continues to solidify its position as a…
### AtriCure's Strategic Growth in Surgical Treatments AtriCure, Inc., a key player in surgical solutions for atrial fibrillation, reports promising financial results for the fourth quarter and full y…
AtriCure's Strategic Innovations Drive Robust Growth in Atrial Fibrillation Treatments AtriCure, Inc., a leader in surgical solutions for atrial fibrillation and related conditions, reports substantia…
AtriCure's Commitment to Innovating Atrial Fibrillation Treatments AtriCure, Inc. stands at the forefront of surgical innovations aimed at combating atrial fibrillation (Afib), a condition that affect…
AtriCure Showcases Commitment to Atrial Fibrillation Innovations at J.P. Morgan Healthcare Conference AtriCure, Inc. continues to solidify its position as a leader in the medical technology sector, pa…
QuantumGate Launch: A Significant Step for Data Security in the Quantum Era VentureOne, the commercialization arm of the Advanced Technology Research Council (ATRC) in Abu Dhabi, has launched QuantumG…
AtriCure's Commitment to Innovation in Atrial Fibrillation Treatment AtriCure, Inc. stands at the forefront of surgical solutions for atrial fibrillation (Afib), a condition that affects over 37 milli…